Skip to main content
OpenTrials
Completed

NCT Number: NCT04351893

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

The CAUSE study is a multicenter study, with domestic (n=4) and international (n=6) study sites. Children and young adults (ages 0-18) who have microtia and/or craniofacial microsomia and their parents are invited to participate. Children and parents are asked to provide a DNA sample (blood or saliva) and are asked to upload a few photos of their face. Parents are asked a short interview. Participants are able to participate from home or at one of four domestic sites.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

INCLUSION:

Cases:

  • Participant with CFM is 0-18 years of age
  • Participant has diagnosis of at least one of the following conditions:
  • Microtia
  • Anotia
  • Facial asymmetry AND preauricular tag(s)
  • Facial asymmetry AND facial tag(s)
  • Facial asymmetry AND epibulbar dermoid
  • Facial asymmetry AND macrostomia (i.e., lateral cleft)
  • Preauricular tag AND epibulbar dermoid
  • Preauricular tag AND macrostomia
  • Facial Tag AND epibulbar dermoid
  • Macrostomia AND epibulbar dermoid
  • Participant's parent or legal guardian has provided written informed consent prior to enrollment into study (for participants younger than 18 years of age).
  • Participant speaks a language in which they are eligible for consent at their enrolling site

Parents:

  • Parent participant is the biological parent of a case participant already eligible and participating in the CAUSE study. Non-genetic parents will be interviewed about their child's known prenatal and genetic family history but will not be asked to provide DNA or have facial photographs taken.
  • Participant speaks a language in which they are eligible for consent at their enrolling site

Other relatives:

  • Other relatives participants, of any age, are related biologically to a case participant already eligible and participating in the CAUSE study from a multiplex family (multiple affected individuals with CFM).
  • Participant speaks a language in which they are eligible for consent at their enrolling site

EXCLUSION:

Cases:

  • Participant is diagnosed with a known syndrome that involves microtia and underdevelopment of the jaw (Townes-Brocks, Treacher-Collins, Branchiootorenal, Nager, or Miller syndromes).
  • Participant has abnormal chromosome studies (karyotype).
  • Participant has mandibular asymmetry due to deformational plagiocephaly or torticollis.

Treatment and study plan

Primary outcomes

  1. Identify Genetic Variants

    Time frame: Through study completion, an average of 1 year.

    To identify genetic variants related to the CFM spectrum using whole genome sequencing

Secondary outcomes

  1. Characterize phenotype

    Time frame: Through study completion, an average of 1 year.

    To characterize the detailed phenotype in individuals with CFM

  2. Characterize markers

    Time frame: Through study completion, an average of 1 year.

    To characterize ancestry markers in individuals with CFM

  3. Coding and non-coding variants

    Time frame: Through study completion, an average of 1 year.

    To assess coding and non-coding variants in selected candidate genes in individuals with CFM

Sponsors and collaborators

Lead sponsor

Seattle Children's Hospital

Other

Collaborators

  • Children's Hospital Los Angeles
  • Children's Hospital of Philadelphia
  • Clinica Comfamiliar Risaralda
  • Hospital Nacional Edgardo Rebagliati Martins
  • Instituto de Investigación Hospital Universitario La Paz
  • Pontificia Universidad Javeriana
  • Universidad Icesi
  • University of North Carolina, Chapel Hill

Registry information

Acronym: CAUSE

Important dates

Study start
2018
Primary completion
2021
Study completion
2023
First posted
Apr 17, 2020
Registry last updated
Apr 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.